45 results on '"Arendrup, M C"'
Search Results
2. Update on antifungal resistance in Aspergillus and Candida
3. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
4. ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
5. ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
6. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi
7. Antifungal use: notable differences in prescription practice and association to epidemiology: W11.2
8. Candida & candins: W17.1
9. ESCMID/ECMM joint clinical guideline for the diagnosis and management of rare invasive yeast infections: W14.2
10. Epidemiology of candidemia in Northern Europe: W11.1
11. Commercial methods for antifungal susceptibility testing of Candida: are they validated for patient care?: M03
12. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme
13. EUCAST Technical Note on Voriconazole and Aspergillus spp.
14. ESCMID guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS
15. ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
16. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
17. ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
18. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
19. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases
20. ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia
21. EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
22. Black yeast-like fungi in skin and nail: it probably matters
23. EUCAST Technical note on Amphotericin B
24. EUCAST technical note on posaconazole*
25. EUCAST technical note on anidulafungin
26. European expert opinion on the management of invasive candidiasis in adults
27. Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis
28. Co-existence of cerebral infection with Rhinocladiella mackenziei and primary central nervous system lymphoma in a HIV-negative patient
29. Detection of candidaemia in patients with and without underlying haematological disease
30. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite
31. Ongoing semi-national surveillance of fungaemia in Denmark: have we cracked the curve?: O4.6
32. Aspergillus spp. and other moulds in air way samples from Danish cystic fibrosis patients: O2.5
33. Azole containing agar plates as a screening tool for azole resistance of Aspergillus fumigatus: O1.1
34. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues
35. Invasive fungal infections: past achievements and challenges ahead
36. Surveillance of aspergillosis by galactomannan testing, culture and histopathology in lung transplant recipients: O452
37. Antifiingals: in vitro activity: S316
38. Semi-national surveillance of fungaemia in Denmark 2004–2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility
39. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
40. The prevalence of Dientamoeba fragilis in patients with suspected enteroparasitic disease in a metropolitan area in Denmark
41. Four cases of Candida albicans infections with isolates developing pink colonies on CHROMagar Candida plates
42. Susceptibility testing of amphotericin B and caspofungin-resistant Candida glabrata isolates: P1735
43. Comparison of histoplasma antigen EIA performed at MiraVista Diagnostics and Statens Serum Institute shows good correlation: P1488
44. Findings of Candida species in critically ill patients in context with pharmacokinetic pharmacodynamic properties of antifungal therapy: P1112
45. Semi-national surveillance of fungaemia in Denmark: species distribution and anti-fungal susceptibility: O334
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.